REFERENCES
- Alber H. F., Dulak J, Frick M, Dichtl W, Schwarzacher S. P., Pachinger O, Weidinger F. Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease. Journal of American College of Cardiology 2002; 39: 1951–1955, [CSA]
- Alber H, Frick M, Dulak J, Dörler J, Zwick R, Dichtl W, Pachinger O, Weidinger F. Vascular endothelial growth factor (VEGF) plasma levels in coronary artery disease. Heart 2005; 91: 365–366, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Arnoletti J. P., Albo D, Granick M. S., Solomon M. P., Castiglioni A, Rothman V. L., Tuszynski G. P. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 1995; 76: 998–1005, [PUBMED], [INFOTRIEVE], [CSA]
- Assmus B, Urbich C, Aicher A, Hofmann W. K., Haendeler J, Rossig L, Spyridopoulos I, Zeiher A. M., Dimmeler S. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circulation Research 2003; 92: 1049–1055, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bertin N, Clezardin P, Kubiak R, Frappart L. Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: Correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Cancer Research 1997; 57: 396–399, [PUBMED], [INFOTRIEVE], [CSA]
- Brouet A, Sonveaux P, Dessy C, Moniotte S, Balligand J. L., Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circulation Research 2001; 89: 866–873, [PUBMED], [INFOTRIEVE], [CSA]
- Clezardin P, Frappart L, Clerget M, Pechoux C, Delmas P. D. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Research 1993; 53: 1421–1430, [PUBMED], [INFOTRIEVE], [CSA]
- de Fraipont F, Nicholson A. C., Feige J. J., Van Meir E. G. Thrombospondins and tumor angiogenesis. Trends in Molecular Medicine 2001; 7: 401–407, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Deramaudt B. M., Braunstein S, Remy P, Abraham N. G. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. Journal of Cellular Biochemistry 1998; 68: 121–127, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Desager J. P., Horsmans Y. Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Clinical Pharmacokinetics 1996; 31: 348–371, [PUBMED], [INFOTRIEVE], [CSA]
- Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtlscherer S, Martin H, Zeiher A. M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. Journal of Clinical Investigation 2001; 108: 391–397, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dimmeler S, Zeiher A. M. Nitric oxide-an endothelial cell survival factor. Cell Death and Differentiation 1999; 6: 964–968, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dulak J, Jozkowicz A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies. Antioxidants and Redox Signaling 2003; 5: 123–132, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green C. J., Pachinger O, Weidinger F, Motterlini R. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxidants and Redox Signaling 2002; 4: 229–240, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dulak J, Jozkowicz A, Frick M, Alber H. F., Dichtl W, Schwarzacher S. P., Pachinger O, Weidinger F. Vascular endothelial growth factor: Angiogenesis, atherogenesis or both?. Journal of American College of Cardiology 2001; 38: 2137–2138, [CSA], [CROSSREF]
- Dulak J, Loboda A, Zagorska A, Jozkowicz A. Complex role of heme oxygenase-1 in angiogenesis. Antioxidants and Redox Signaling 2004; 6: 858–866, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Frick M, Dulak J, Cisowski J, Jozkowicz A, Zwick R, Alber H, Dichtl W, Schwarzacher S. P., Pachinger O, Weidinger F. Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. Atherosclerosis 2003; 170: 229–236, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin G. D., Cleutjens J. P., Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert J. M., Smits J. F., Shapiro S. D., Baes M, Borgers M, Collen D, Daemen M. J., Carmeliet P. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nature Medicine 1999; 5: 1135–1142, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jozkowicz A, Dulak J, Prager M, Nanobashvili J, Nigisch A, Winter B, Weigel G, Huk I. Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner. Prostaglandins and Other Lipid Mediators 2001; 66: 165–177, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jozkowicz A, Dulak J, Nigisch A, Funovics P, Weigel G, Polterauer P, Huk I, Malinski T. Involvement of nitric oxide in angiogenic activities of vascular endothelial growth factor isoforms. Growth Factors 2004; 22: 19–28, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Józkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, Dulak J. Heme oxygenase and angiogenic activity of endothelial cells: Stimulation by carbon monoxide, inhibition by tin protoporphyrin-X. Antioxidants and Redox Signaling 2003; 5: 155–162, [CSA], [CROSSREF]
- Kaneta S, Satoh K, Kano S, Kanda M, Ichihara K. All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells. Atherosclerosis 2003; 170: 237–243, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kaushal V, Kohli M, Mehta P, Mehta J. L. Potential anticancer effect of statins: Fact or fiction. Endothelium 2003; 10: 49–58, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Korff T, Augustin H. G. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. Journal of Cell Biology 1998; 143: 1341–1352, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer D. J., Sessa W. C., Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nature Medicine 2000; 6: 1004–1010, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Laderoute K. R., Alarcon R. M., Brody M. D., Calaoagan J. M., Chen E. Y., Knapp A. M., Yun Z, Denko N. C., Giaccia A. J. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. Clinical Cancer Research 2000; 6: 2941–2950, [PUBMED], [INFOTRIEVE], [CSA]
- Laufs U, Fata V. L., Liao J. K. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. Journal of Biological Chemistry 1997; 272: 31725–31729, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Laufs U, La Fata V, Plutzky J, Liao J. K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129–1135, [PUBMED], [INFOTRIEVE], [CSA]
- Lawler J, Detmar M. Tumor progression: The effects of thrombospondin-1 and -2. International Journal of Biochemistry and Cell Biology 2004; 36: 1038–1045, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lee T. S., Chang C. C., Zhu Y, Shyy J. Y. Simvastatin induces heme oxygenase-1: A novel mechanism of vessel protection. Circulation 2004; 110: 1296–1302, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lennernas H. Clinical pharmacokinetics of atorvastatin. Clinical Pharmacokinetics 2003; 42: 1141–1160, [PUBMED], [INFOTRIEVE], [CSA]
- Li A, Dubey S, Varney M. L., Dave B. J., Singh R. K. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. Journal of Immunology 2003; 170: 3369–3376, [CSA]
- Liao J. K., Laufs U. Pleiotropic effects of statins. Annual Reviews in Pharmacology and Toxicology 2004; 45: 89–118, Aug 17[CSA], [CROSSREF]
- Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, Walsh K, Isner J. M., Asahara T. HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells. Journal of Clinical Investigation 2001; 108: 399–405, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Motegi K, Harada K, Pazouki S, Baillie R, Schor A. M. Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis. Histochemical Journal 2002; 34: 411–421, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Moulton K. S., Heller E, Konerding M. A., Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999; 99: 1726–1732, [PUBMED], [INFOTRIEVE], [CSA]
- Moulton K. S., Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo K. M., Gillies S, Javaherian K, Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proceedings of the National Acadaemy of Sciences of the United States of America 2003; 100: 4736–4741, [CSA], [CROSSREF]
- Muck A. O., Seeger H, Wallwiener D. Class-specific pro-apoptotic effect of statins on human vascular endothelial cells. Zeischrift für Kardiologie 2004; 93: 398–402, [CSA], [CROSSREF]
- Newton C. J., Xie Y. X., Burgoyne C. H., Adams I, Atkin S. L., Abidia A, McCollum P. T. Fluvastatin induces apoptosis of vascular endothelial cells: Blockade by glucocorticoids. Cardiovascular Surgery 2003; 11: 52–60, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Phelan M. W., Forman L. W., Perrine S. P., Faller D. V. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. Journal of Laboratory and Clinical Medicine 1998; 132: 519–529, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rezaie-Majd A, Prager G. W., Bucek R. A., Schernthaner G. H., Maca T, Kress H G., Valent P, Binder B. R., Minar E, Baghestanian M. Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arteriosclerosis, Thrombosis and Vascular Biology 2003; 23: 397–403, [CSA], [CROSSREF]
- Rodriguez-Porcel M, Lerman A, Ritman E. L., Wilson S. H., Best P. J., Lerman L. O. Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia. Circulation 2000; 102: 2028–2030, [PUBMED], [INFOTRIEVE], [CSA]
- Sata M, Nishimatsu H, Osuga J, Tanaka K, Ishizaka N, Ishibashi S, Hirata Y, Nagai R. Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis. Hypertension 2004; 43: 1214–1220, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sata M, Nishimatsu H, Suzuki E, Sugiura S, Yoshizumi M, Ouchi Y, Hirata Y, Nagai R. Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia. FASEB Journal 2001; 15: 2530–2532, [PUBMED], [INFOTRIEVE], [CSA]
- Sikorski E. M., Hock T, Hill-Kapturczak N, Agarwal A. The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury. American Journal of Physiology Renal Physiology 2004; 286: F425–F441, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Undas A, Celinska-Lowenhoff M, Kaczor M, Musial J. New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thrombosis Haemostasis 2004; 91: 1065–1077, [CSA]
- Urbich C, Dernbach E, Zeiher A. M., Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circulation Research 2002; 90: 737–744, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Waehre T, Damas J. K., Gullestad L, Holm A. M., Pedersen T. R., Arnesen K. E., Torsvik H, Froland S. S., Semb A. G., Aukrust P. Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease. Journal of American College of Cardiology 2003; 41: 1460–1467, [CSA], [CROSSREF]
- Wang-Rodriguez J, Urquidi V, Rivard A, Goodison S. Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status. Breast Cancer Research 2003; 5: R136–R143, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wassmann S, Nickening G. Interrelationship of free radicals and endothelial dysfunction—modulation by statins. Endothelium 2003; 10: 23–33, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Weinstat-Saslow D. L., Zabrenetzky V. S., VanHoutte K, Frazier W. A., Roberts D. D., Steeg P. S. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Research 1994; 54: 6504–6511, [PUBMED], [INFOTRIEVE], [CSA]
- Weis M, Heeschen C, Glassford A. J., Cooke J. P. Statins have biphasic effects on angiogenesis. Circulation 2002; 105: 739–745, [PUBMED], [INFOTRIEVE], [CSA]
- Wiesbauer F, Kaun C, Zorn G, Maurer G, Huber K, Wojta J. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: A comparative study using different statins. British Journal of Pharmacology 2002; 135: 284–292, [PUBMED], [INFOTRIEVE], [CSA]
- Wilson S. H., Herrmann J, Lerman L. O., Holmes D. R., Jr, Napoli C, Ritman E. L., Lerman A. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 2002; 105: 415–418, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wong W. W., Dimitroulakos J, Minden M. D., Penn L. Z. HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002; 16: 508–519, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovascular Research 2001; 49: 568–581, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]